|
1
|
Warren S and Gates O: Multiple primary
malignant tumors. A survey of the literature and stasistical study.
Am J Cancer. 16:1358–1414. 1932.
|
|
2
|
Liu F, Qin D and Wang Q: Clinical
pathological analysis of 172 cases with multiple primary carcinoma.
Chin J Oncol. 1:113–119. 1979.
|
|
3
|
Moertel CG, Dockerty MB and Baggenstoss
AH: Multiple primary malignant neoplasms. I. Introduction and
presentation of data. Cancer. 14:221–230. 1961. View Article : Google Scholar
|
|
4
|
Shi L, Zhou S, Jiang Y, Wan Y, Ma J, Fu S
and Cheng W: Gynecological malignant tumor related multiple primary
malignant neoplasms: Clinical analysis of 30 cases. Zhonghua Fu
Chan Ke Za Zhi. 49:199–203. 2014.
|
|
5
|
Xu LL and Gu KS: Clinical retrospective
analysis of cases with multiple primary malignant neoplasms. Genet
Mol Res. 13:9271–9284. 2014. View Article : Google Scholar
|
|
6
|
Wang Y, Jiao F, Yao J, Zhou X, Zhang X and
Wang L: Clinical features of multiple primary malignant tumors: A
retrospective clinical analysis of 213 Chinese patients at two
centers. Discov Med. 32:65–78. 2021.
|
|
7
|
Vogt A, Schmid S, Heinimann K, Frick H,
Herrmann C, Cerny T and Omlin A: Multiple primary tumours:
Challenges and approaches, a review. ESMO Open. 2:e0001722017.
View Article : Google Scholar
|
|
8
|
Pauli C, De Boni L, Pauwels JE, Chen Y,
Planas-Paz L, Shaw R, Emerling BM, Grandori C, Hopkins BD and Rubin
MA: A functional precision oncology approach to identify treatment
strategies for myxofibrosarcoma patients. Mol Cancer Res.
20:244–252. 2022. View Article : Google Scholar
|
|
9
|
Rachdi I, Daoud F, Khanchel F, Arbaoui I,
Somai M, Zoubeidi H, Aydi Z, Ben Dhaou B, Debbiche A and Boussema
F: Myxofibrosarcoma of the leg: A diagnostic challenge. Clin Case
Rep. 8:3332–3335. 2020. View Article : Google Scholar
|
|
10
|
Zhang P, Ruan SF, Huang J, Gong T and Ji
C: Multiple cutaneous myxofibrosarcoma on the right arm:
Clinicopathological features and differential diagnosis. Authorea.
2023.
|
|
11
|
Vanni S, De Vita A, Gurrieri L, Fausti V,
Miserocchi G, Spadazzi C, Liverani C, Cocchi C, Calabrese C,
Bongiovanni A, et al: Myxofibrosarcoma landscape: Diagnostic
pitfalls, clinical management and future perspectives. Ther Adv Med
Oncol. 14:175883592210939732022. View Article : Google Scholar
|
|
12
|
Fernebro J, Bladström A, Rydholm A,
Gustafson P, Olsson H, Engellau J and Nilbert M: Increased risk of
malignancies in a population-based study of 818 soft-tissue sarcoma
patients. Br J Cancer. 95:986–990. 2006. View Article : Google Scholar
|
|
13
|
Tateishi U, Hasegawa T, Yamamoto S,
Yamaguchi U, Yokoyama R, Kawamoto H, Satake M and Arai Y: Incidence
of multiple primary malignancies in a cohort of adult patients with
soft tissue sarcoma. Jpn J Clin Oncol. 35:444–452. 2005. View Article : Google Scholar
|
|
14
|
Sanfilippo R, Miceli R, Grosso F, Fiore M,
Puma E, Pennacchioli E, Barisella M, Sangalli C, Mariani L, Casali
PG and Gronchi A: Myxofibrosarcoma: Prognostic factors and survival
in a series of patients treated at a single institution. Ann Surg
Oncol. 18:720–725. 2011. View Article : Google Scholar
|
|
15
|
Mentzel T, Calonje E, Wadden C, Camplejohn
RS, Beham A, Smith MA and Fletcher CD: Myxofibrosarcoma.
Clinicopathologic analysis of 75 cases with emphasis on the
low-grade variant. Am J Surg Pathol. 20:391–405. 1996. View Article : Google Scholar
|
|
16
|
Neagu TP, Sinescu RD, Enache V, Achim SC,
Ţigliş M and Mirea LE: Metastatic high-grade myxofibrosarcoma:
Review of a clinical case. Rom J Morphol Embryol. 58:603–609.
2017.
|
|
17
|
Look Hong NJ, Hornicek FJ, Raskin KA, Yoon
SS, Szymonifka J, Yeap B, Chen YL, DeLaney TF, Nielsen GP and
Mullen JT: Prognostic factors and outcomes of patients with
myxofibrosarcoma. Ann Surg Oncol. 20:80–86. 2013. View Article : Google Scholar
|
|
18
|
Castaigne C, Martin P and Blocklet D:
Lung, gastric, and soft tissue uptake of Tc-99m MDP and Ga-67
citrate associated with hypercalcemia. Clin Nucl Med. 28:467–471.
2003. View Article : Google Scholar
|
|
19
|
Flores LGI, Nagamachi S, Jinnouchi S,
Ohnishi T, Futami S, Nakahara H and Tamura S: Relationship between
extraosseous accumulation in bone scintigraphy with 99Tcm-HMDP and
histopathology. Nucl Med Commun. 19:347–354. 1998. View Article : Google Scholar
|
|
20
|
Zeng D, Chen Y, Cai L and Zhou F: Analysis
of abnormal uptake of extraskeletal soft tissue in
99mTc-MDP whole bone scan. Chongqing Med J.
45:2073–2077. 2016.(In Chinese).
|
|
21
|
Ostergaard L, Tietze A, Nielsen T, Drasbek
KR, Mouridsen K, Jespersen SN and Horsman MR: The relationship
between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic
glycolysis. Cancer Res. 73:5618–5624. 2013. View Article : Google Scholar
|
|
22
|
Buckley O, O'Keeffe S, Geoghegan T, Lyburn
ID, Munk PL, Worsley D and Torreggiani WC: 99mTc bone scintigraphy
superscans: A review. Nucl Med Commun. 28:521–527. 2007. View Article : Google Scholar
|
|
23
|
Ren JYL, Li Y and Luo Y: Differentiation
of superscan in 99TCm-MDP bone scintigraphy:
A case report. Chin J Nucl Med Mol Imaging. 39:39–40. 2019.(In
Chinese).
|
|
24
|
Askari E, Shakeri S, Roustaei H, Fotouhi
M, Sadeghi R, Harsini S and Vali R: Superscan pattern on bone
scintigraphy: A comprehensive review. Diagnostics (Basel).
14:22292024. View Article : Google Scholar
|
|
25
|
Kovacsne A, Kozon I, Bentestuen M and
Zacho HD: Frequency of superscan on bone scintigraphy: A systematic
review. Clin Physiol Funct Imaging. 43:297–304. 2023. View Article : Google Scholar
|
|
26
|
Prakash R: Incidental detection of
skeletal metastases on technetium-99m DTPA renal scintigraphy.
Australas Radiol. 39:182–184. 1995. View Article : Google Scholar
|
|
27
|
Ogura K, Hosoda F, Arai Y, Nakamura H,
Hama N, Totoki Y, Yoshida A, Nagai M, Kato M, Arakawa E, et al:
Integrated genetic and epigenetic analysis of myxofibrosarcoma. Nat
Commun. 9:27652018. View Article : Google Scholar
|
|
28
|
Bui NQ, Przybyl J, Trabucco SE, Frampton
G, Hastie T, van de Rijn M and Ganjoo KN: A clinico-genomic
analysis of soft tissue sarcoma patients reveals CDKN2A deletion as
a biomarker for poor prognosis. Clin Sarcoma Res. 9:122019.
View Article : Google Scholar
|
|
29
|
Kleiburg F, van der Hulle T, Gelderblom H,
Slingerland M, Speetjens FM, Hawinkels LJAC, Dibbets-Schneider P,
van Velden FHP, Pool M, Lam SW, et al: PSMA expression and PSMA
PET/CT imaging in metastatic soft tissue sarcoma patients, results
of a prospective study. Eur J Nucl Med Mol Imaging. 52:3690–3699.
2025. View Article : Google Scholar
|
|
30
|
Spiridon IA, Ong SLM, Soukup J,
Topirceanu-Andreoiu OM, de Geus-Oei LF, Gelderblom H, Lam SW, de
Bruijn IHB, Akker BEWMVD, Hijmen L, et al: Neovascular prostate
specific membrane antigen (PSMA) expression in bone and soft tissue
sarcoma: A systematic analysis. Virchows Arch. Apr 9–2025.(Epub
ahead of print). View Article : Google Scholar
|
|
31
|
Deivaraju C, Temple HT, Block N, Robinson
P and Schally AV: LHRH receptor expression in sarcomas of bone and
soft tissue. Horm Mol Biol Clin Investig. 28:105–111. 2016.
View Article : Google Scholar
|
|
32
|
Wu H, Li J, Yao R, Liu J, Su L and You W:
Focusing on the interplay between tumor-associated macrophages and
tumor microenvironment: from mechanism to intervention.
Theranostics. 15:7378–7408. 2025. View Article : Google Scholar
|
|
33
|
Zhang Z and Wu Y: Research progress on
mechanisms of tumor immune microenvironment and gastrointestinal
resistance to immunotherapy: Mini review. Front Immunol.
16:16415182025. View Article : Google Scholar
|
|
34
|
Nair R, Somasundaram V, Kuriakose A,
Krishn SR, Raben D, Salazar R and Nair P: Deciphering T-cell
exhaustion in the tumor microenvironment: Paving the way for
innovative solid tumor therapies. Front Immunol. 16:15482342025.
View Article : Google Scholar
|
|
35
|
Swaroop VS, Winawer SJ, Kurtz RC and
Lipkin M: Multiple primary malignant tumors. Gastroenterology.
93:779–783. 1987. View Article : Google Scholar
|
|
36
|
Liu F, Qin D and Wang Q: Clinical and
pathological analysis of 172 cases of multiple primary cancers.
Chin J Oncol. 1:113–119. 1979.(In Chinese).
|
|
37
|
Adamo M, Johnson C, Ruhl J and Dicki L:
SEER program coding and staging manual. NIH publication number
12-5581. National Cancer Institute; Bethesda, MD: 2012
|
|
38
|
Working Group Report: International rules
for multiple primary cancers (ICD-0 third edition). Eur J Cancer
Prev. 14:307–308. 2005. View Article : Google Scholar
|
|
39
|
Tichansky DS, Cagir B, Borrazzo E, Topham
A, Palazzo J, Weaver EJ, Lange A and Fry RD: Risk of second cancers
in patients with colorectal carcinoids. Dis Colon Rectum. 45:91–97.
2002. View Article : Google Scholar
|
|
40
|
Ito K, Masuda-Miyata Y, Wada S, Morooka M,
Yamasawa K, Hashimoto M and Kubota K: F-18 FDG PET/CT imaging of
bulky myxofibrosarcoma in chest wall. Clin Nucl Med. 36:212–213.
2011. View Article : Google Scholar
|
|
41
|
Younis MH, Abu-Hijleh HA, Aldahamsheh OO,
Abualruz A and Thalib L: Meta-analysis of the diagnostic accuracy
of primary bone and soft tissue sarcomas by 18F-FDG-PET. Med Princ
Pract. 29:465–472. 2020. View Article : Google Scholar
|
|
42
|
Kassem TW, Abdelaziz O and Emad-Eldin S:
Diagnostic value of 18F-FDG-PET/CT for the follow-up and
restaging of soft tissue sarcomas in adults. Diagn Interv Imaging.
98:693–698. 2017. View Article : Google Scholar
|
|
43
|
Shen G, Deng H, Hu S and Jia Z: Comparison
of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the
diagnosis of bone metastases in patients with prostate cancer: A
meta-analysis. Skeletal Radiol. 43:1503–1513. 2014. View Article : Google Scholar
|
|
44
|
de Leiris N, Leenhardt J, Boussat B,
Montemagno C, Seiller A, Phan Sy O, Roux J, Laramas M, Verry C,
Iriart C, et al: Does whole-body bone SPECT/CT provide additional
diagnostic information over [18F]-FCH PET/CT for the detection of
bone metastases in the setting of prostate cancer biochemical
recurrence? Cancer Imaging. 20:582020. View Article : Google Scholar
|
|
45
|
Zamani-Siahkali N, Mirshahvalad SA, Farbod
A, Divband G, Pirich C, Veit-Haibach P, Cook G and Beheshti M:
SPECT/CT, PET/CT, and PET/MRI for response assessment of bone
metastases. Semin Nucl Med. 54:356–370. 2024. View Article : Google Scholar
|
|
46
|
Hu X, Cao Y, Ji B, Zhao M, Wen Q and Chen
B: Comparative study of 18F-DCFPyL PET/CT and
99mTc-MDP SPECT/CT bone imaging for the detection of
bone metastases in prostate cancer. Front Med (Lausanne).
10:12019772023. View Article : Google Scholar
|
